Dr. Xinhua Xie 谢新华
Chief Physician
Department of Breast Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Early diagnosis of breast cancer, breast-conserving and modified radical mastectomy, minimally invasive and laparoscopic surgery for breast tumors, and breast reconstruction.
Dr. Xie is Deputy Director of the Breast Department and a Chief Physician at Sun Yat-sen University Cancer Center. With nearly 20 years of clinical experience in breast cancer, Dr. Xie supervises doctoral students. Dr. Xie has led three projects, including National Natural Science Foundation grants, and published over 20 SCI papers as first or corresponding author.
Professional roles
- Chair, Smart Breast Cancer Branch, Guangdong Health Information Network Association
- Vice Chair, Precision Medicine Breast Cancer Branch, Guangdong Province
- Standing Committee Member, Breast Cancer Professional Committee, Guangdong Anti-Cancer Association
- Standing Committee Member, Oncologic Plastic Surgery Professional Committee, Guangdong Anti-Cancer Association
Name order: in Chinese the family name comes first (Xie Xinhua). Papers usually list the name as Xinhua Xie or Xie X.
Selected publications
85 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Adv Res, 2026 (senior author): ZUP1 promotes DNA repair and immune evasion to drive olaparib resistance in triple-negative breast cancer. PubMed 41253271
- Gland Surg, 2025 (senior author): Immediate lymphatic reconstruction (ILR) for prevention of secondary lymphedema after breast cancer surgery: a systematic review and meta‑analysis. PubMed 40948921
- Oncol Res, 2025 (senior author): OTUB2 promotes proliferation and metastasis of triple-negative breast cancer by deubiquitinating TRAF6. PubMed 40296903
- Cell Death Discov, 2024 (senior author): PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer. PubMed 38182573
- J Cancer Res Clin Oncol, 2023 (senior author): Identification of lactate-related subgroups and prognostic model in triple-negative breast cancer. PubMed 37474680
- Front Cell Dev Biol, 2022 (senior author): Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer. PubMed 35656548
- Front Cell Dev Biol, 2022 (senior author): Integrative Analysis of Gene Expression and DNA Methylation Depicting the Impact of Obesity on Breast Cancer. PubMed 35350384
- Front Oncol, 2019 (first author): Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer. PubMed 31781496
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion